| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | $513.02M | $490.74M | $572.42M | $547.66M | $89.61M |
| Cost of Revenue | – | – | – | – | $59.45M |
| Gross Profit | – | – | – | – | $30.16M |
| Operating Expenses | – | – | – | – | $35.77M |
| R&D | – | – | – | – | $405.00K |
| SG&A | $71.10M | $77.03M | $108.23M | $82.44M | $30.38M |
| Operating Income | -$30.90M | -$86.41M | -$81.46M | -$263.45M | -$5.62M |
| Interest Expense | – | $4.28M | $43.02M | $29.70M | $1.68M |
| Tax Expense | -$19.14M | -$21.88M | -$19.34M | -$15.19M | -$4.78M |
| Net Income | -$68.63M | -$108.44M | -$105.14M | -$337.02M | $10.89M |
| EPS (basic) | -2.1100 | -4.1900 | -4.1000 | -13.8400 | 0.8300 |
| EPS (diluted) | -2.1100 | -4.1900 | -4.1000 | -13.8400 | 0.1900 |
| Shares (diluted) | $32.45M | $25.90M | $25.64M | $24.35M | $13.87M |